Jun 8, 2024, 10:07
Ari Rosenberg: Our OPTIMA II trial is out in JAMA Oncology
Ari Rosenberg, Medical Oncologist and Assistant Professor at the University of Chicago, shared a post on X: ,
“Excited that our OPTIMA II trial is out in JAMA Oncology!
Neoadjuvant nivolumab/chemotherapy -> response-adaptive treatment for HPV+ oropharyngeal cancer.”
Proceed to the article.
Source: Ari Rosenberg/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 1, 2024, 17:46
Nov 1, 2024, 17:41
Nov 1, 2024, 17:27
Nov 1, 2024, 17:12
Nov 1, 2024, 17:09
Nov 1, 2024, 17:05